register

News & Trends - MedTech & Diagnostics

First patients benefit from Elekta’s cutting-edge technology

Health Industry Hub | April 9, 2021 |

MedTech News: The first Gamma Knife to be installed in Victoria, at Peter MacCallum Cancer Centre, is now fully operational with the first patients to receive the non-invasive radiosurgery.

Elekta’s Gamma Knife is a cutting-edge technology that uses radiation to precisely target and treat tumours and other neurological conditions. It is an alternative to traditional brain surgery and whole brain radiation therapy for the treatment of complex, difficult-to-access brain conditions.

Peter Mac Department of Radiation Oncology Deputy Director and lead clinician for the Victorian Gamma Knife Service, Dr Claire Phillips said the first patients had been referred and treated within the new Victorian Gamma Knife Service based at Peter Mac.

“The Gamma Knife is completely non-invasive and in just one session, without the use of anaesthesia, we can precisely target and treat one or multiple tumours, with the patient going home straight afterwards,” Dr Phillips said.

“Early patient results are positive, and this cutting-edge technology will improve the lives of hundreds of Victorians whose treatment was previously considered off limits to even the most skilled surgeons.”

Florence Lagier was booked for neurosurgery for her vestibular schwannoma (sometimes called acoustic neuroma) when, in late 2020, she learned that Gamma Knife was coming to Peter Mac.

“I asked to have the Gamma Knife procedure instead of the invasive surgery,” Ms Lagier said.

“My recovery time would have been six to eight weeks however, with the Gamma Knife, the recovery time is nil and I can go home the same day with less stress for me and my family.”

The Gamma Knife is a stereotactic radiotherapy machine designed specifically to treat the head. It can treat tumours, vascular malformations and other abnormalities – with minimal effect on healthy tissue.

It also offers a benefit over other forms of radiotherapy which typically require the patient to return for many successive treatment sessions to receive the required therapeutic dose.

The Gamma Knife at Peter Mac is the first in Victoria and only the third in Australia, and Victoria’s Gamma Knife service expected to treat up to 500 patients per year. The other two sites with Gamma Knife include Princess Alexandra Hospital in Brisbane and Macquarie University Hospital in Sydney.

The $8 million Gamma Knife was co-funded equally by the Victorian Government and through the generous donations to the Peter MacCallum Cancer Foundation.


News & Trends - MedTech & Diagnostics

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Policy paralysis: Private hospitals left to clean up the government’s mess on medical device reforms

Health Industry Hub | April 17, 2025 |

Hospitals shouldn’t be forced to grovel to private health insurers to secure funding for essential, lifesaving medical devices. But thanks […]

More


News & Trends - Pharmaceuticals

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Oncologists pioneer liquid biopsy-guided treatment in lung cancer

Health Industry Hub | April 17, 2025 |

Lung cancer is Australia’s leading cause of cancer deaths. Local experts are set to lead a new frontier in personalised […]

More


Medical and Science

The high cost of record low research funding

The high cost of record low research funding

Health Industry Hub | April 17, 2025 |

Australia has delivered some of the world’s most transformative health and medical breakthroughs – the cochlear implant, the HPV vaccine, […]

More


News & Trends - Pharmaceuticals

UCB secures dermatology indication with first dual IL-17A/F inhibitor

UCB secures dermatology indication with first dual IL-17A/F inhibitor

Health Industry Hub | April 17, 2025 |

UCB’s IL-17A and IL-17F inhibitor has been added to the Australian Register of Therapeutic Goods (ARTG) for adults with moderate […]

More


This content is copyright protected. Please subscribe to gain access.